At a recent workshop for EU Member States National Competent Authority (NCA) experts organised by (the European Medicines Verification Organisation (EMVO) and supported by the European Commission / DG SANTE, the new process for onboarding Pharmaceutical Manufacturers to the European Hub was presented.
The Legitimacy Check is a crucial aspect of the process of giving access to this critical module of the European Medicines Verification System (EMVS). It’s aim is to ensure that only legitimate pharmaceutical businesses are able to upload Serialised Pack data (Unique Identifiers) to the European Hub.
We are proud that 3C Excellis, who are supporting the EMVO Commercial and Partnership Management Team, have played a leading role in delivering this critical process.
More information is available on the EMVO website (though for obvious reasons, details of how the legitimacy checks are carried out will not be released):